Eight-week oral administration of meloxicam, a...

Hepatology Research 2008 Vol. 38; Iss. 3

Eight-week oral administration of meloxicam, a non-steroidal anti-inflammatory drug, prevents dose reduction of pegylated interferon α-2a in the treatment of chronic hepatitis C

Tatehiro Kagawa, Hirokazu Shiozawa, Sei-ichiro Kojima, Shinji Takashimizu, Naruhiko Nagata, Makoto Numata, Fumitoshi Morino, Yasuhiro Nishizaki, Kaori Mochizuki, Norihito Watanabe, Tetsu Watanabe, Sho
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
38
Year:
2008
Language:
english
DOI:
10.1111/j.1872-034x.2007.00260.x
File:
PDF, 121 KB
english, 2008
Conversion to is in progress
Conversion to is failed